Fennec Pharmaceuticals Announces Clinical Research Collaboration with Tampa General Hospital Cancer Institute
Study is Real-World Evaluation of the Clinical Utility of Sodium Thiosulfate Injection (PEDMARK®)…
Illumina Launches TruPath Genome, Unveils NovaSeq X Roadmap, and Drives Cancer Breakthroughs with Connected Multiomics
TruPath™ Genome offers more complete genome, with the simplest sample to sequencer…
ICPO and UroTeragLATAM signed a strategic agreement to accelerate Theranostics for urological cancer in Latin America
The partnership strengthens education, innovation, and patient access by combining global expertise…
Manipal Hospital Yeshwanthpur Honors Childhood Cancer Warriors on International Childhood Cancer Day 2026
BENGALURU, India, Feb. 25, 2026 /PRNewswire/ -- In the spirit of Childhood Cancer…
Discovery linking gut bacteria to cancer treatment wins the Bial Award in Biomedicine and earns 350,000 prize
A study published in Science reveals that a healthy gut microbiota can…
Kyntra Bio Announces Positive Data from the Investigator-Sponsored Phase 1b/2 Study of FG-3246 in Combination with Enzalutamide in Patients with Metastatic Castration Resistant Prostate Cancer to Be Presented at ASCO GU 2026
February 23, 2026 17:10 ET | Source: Kyntra Bio FG-3246 and enzalutamide…
New Guidelines from NCCN Detail Fundamental Differences in Cancer in Children Compared to Adults
National Comprehensive Cancer Network publishes new guidelines for Pediatric Soft Tissue Sarcomas,…
Manipal Hospital Kanakapura Road Commits to Managing Cancer with Compassion and Competence with Comprehensive Cancer Centre (MCCC) Launch
BANGALORE, India, Feb. 6, 2026 /PRNewswire/ -- Strengthening India's fight against cancer,…
NCCN Commemorates World Cancer Day with New Commitment to Update Patient Resources
The National Comprehensive Cancer Network pledges to update robust information resources for…
Dewpoint Therapeutics Doses First Patient in Phase 1a/2a Trial DPTX3186 for the Treatment of Advanced Solid Tumors, Focused on Gastric Cancer
DPTX3186, a first-in-class beta-catenin condensate modulator, received Orphan Drug Designation and Fast…
